Can Nasal Nitric Oxide Aid PCD Diagnosis? - Summary - MDSpire
From the Journals

Can Nasal Nitric Oxide Aid PCD Diagnosis?

Evidence synthesis shows strong diagnostic performance but highlights variability across subgroups and clinical settings

Share

Nasal nitric oxide (nNO) measurement shows high diagnostic accuracy for primary ciliary dyskinesia (PCD), a rare genetic disorder affecting mucociliary clearance. A review by Eric Gerardus Haarman from Amsterdam University Medical Center evaluates nNO's performance against reference standards, noting a sensitivity of 98% and specificity of 96% in comprehensive analyses. However, nNO should not be a standalone test and must be paired with other diagnostic methods to effectively identify PCD, as performance varies with genetic and clinical factors, including age and infection status.

Original Source(s)

Can Nasal Nitric Oxide Aid PCD Diagnosis?

  • by Andrea Surnit

  • April 13, 2026

Related Content

FDA Flags Missing Trial Results

Federal outreach seeks to improve compliance with ClinicalTrials.gov reporting requirements and make more complete clinical trial information publicly available

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models

Utah Just Let an Algorithm Write Prescriptions

Physician oversight waived in state sandbox; federal review status unclear